A RECENT three-year US study
into the use of Vitamin B6 and
B12 to reduce the progression of
diabetic nephropathy has turned
up some unexpected results,
including the potential for high
doses of B Vitamins to harm
kidneys and increase the risk of
cardiovascular disease, with a
possible correlation between high
levels of Vit B and a doubling of
the risk of myocardial infarction.The above article was sent to subscribers in Pharmacy Daily's issue from 03 May 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 May 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.